According to Strides Pharma's latest financial reports and stock price the company's current Operating Margin is -5.19%. At the end of 2022 the company had an Operating Margin of -21.59%.
Year | Operating Margin | Change |
---|---|---|
2022 | -21.59% | -354.86% |
2021 | 8.47% | 311.63% |
2020 | 2.06% | -15.91% |
2019 | 2.45% | -14.38% |
2018 | 2.86% | -67.71% |
2017 | 8.85% | 4.19% |
2016 | 8.50% | -35.26% |
2015 | 13.13% | |
2012 | 43.07% | 298.75% |
2011 | 10.80% | -1.71% |
2010 | 10.99% | 0.32% |
2009 | 10.95% | -2.7% |
2008 | 11.26% | -336.33% |
2007 | -4.76% | -153.2% |
2006 | 8.96% | -20.81% |
2005 | 11.31% | -6.22% |
2004 | 12.06% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.